Translational Oncology Research, LLC is a privately held company that is focused upon discovering and rediscovering cancer treatment and chemoprevention options that have not made it to the mainstream.
Research sources range from ancient manuscripts and historical accounts through today’s most cutting edge technological breakthroughs.
Critical to our efforts are the identification of convergences and the mechanisms that drive those convergences.
The company views its responsibilities to include the provision of this information to the general public – and the exploration and exploitation of whatever commercial opportunities that information might provide.